Koyfin Home > Directory > Health Care > Adverum Biotechnlgs > Cash from Financing Activities

Adverum Biotechnlgs Cash from Financing Activities Chart (ADVM)

Adverum Biotechnlgs annual/quarterly Cash from Financing Activities from 2013 to 2020.
  • Adverum Biotechnlgs Cash from Financing Activities for the quarter ending June 06, 2020 was $3m a 103.33% increase of 3m year over year
  • Adverum Biotechnlgs Cash from Financing Activities for the last 12 months ending June 06, 2020 was $178m a 99.21% increase of 177m year over year
  • Adverum Biotechnlgs Annual Cash from Financing Activities for 2019 was $28m a -148.13% decrease of -42m from 2018
  • Adverum Biotechnlgs Annual Cash from Financing Activities for 2018 was $70m a 76.06% increase of 53m from 2017
  • Adverum Biotechnlgs Annual Cash from Financing Activities for 2017 was $17m a 96.68% increase of 16m from 2016
Other Cash Flow Metrics:
  • Adverum Biotechnlgs Cash Flow from Operations for the quarter ending December 12, 2018 was $-13m a -2.00% increase of 0m year over year
  • Adverum Biotechnlgs Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-26m a 70.14% decrease of -18m year over year
  • Adverum Biotechnlgs Total Revenue for the quarter ending September 09, 2018 was $1m a 44.66% increase of 0m year over year
View Chart On Koyfin

Quarterly ADVM Cash from Financing Activities Data

06/2020$3m
03/2020$149m
12/2019$27m
09/2019$0m
06/2019$2m
03/2019$0m
12/2018$0m
09/2018$0m
06/2018$0m
03/2018$70m

Annual ADVM Cash from Financing Activities Data

2019$28m
2018$70m
2017$17m
2016$1m
2015$139m
2014$165m
2013$2m
2012$1m